Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison.
Jean-Guillaume LetarouillyBenoît FlachaireCéline LabadieMaéva KyhengNicolas CohenJérémie SellamPascal RichettePhilippe DieudePascal ClaudepierreBruno FautrelEric HouvenagelChi Duc NguyenMarie-Hélène GuyotNicolas SegaudLaurent MarguerieXavier DeprezJean-Hugues SalmonGuy BaudensCorinne Miceli-RichardElisabeth GervaisIsabelle Chary-ValckenaerePierre LafforguePeggy PhilippeDamien LoeuilleChristophe RichezFlorence TubachThao PhamRené-Marc FlipoPublished in: Rheumatology (Oxford, England) (2021)
In this first study comparing UST and SEK, the persistence of SEK was higher than that of UST in PsA. In subgroup analysis, this difference was only found in association with MTX.